SEC Tracker
Get the app

AngioDynamics ANGO

AngioDynamics reports Q1 2027 results

Form
8-K
Filed
Importance
Routine
  1. Net sales of $80.9M, up 6.9% YoY.
  2. Med Tech sales up 13.2% to $39.9M.
  3. Adjusted EBITDA of $5.0M.
  4. FDA approves NanoKnife IRE for BPH study.

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when AngioDynamics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Orthofix Medical OFIX public float $440M, Jun 30, 2025
  2. Axogen AXGN public float $431M, Jun 30, 2025
  3. Delcath Systems DCTH public float $420M, Jun 30, 2025
  4. Ceribell CBLL public float $417M, Jun 30, 2025
  5. Iradimed IRMD public float $481M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.